Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1969 Aug;32(4):324–327. doi: 10.1136/jnnp.32.4.324

Lactate dehydrogenase and glutamic oxalacetic transaminase of the cerebrospinal fluid in tumours of the central nervous system.

G A Davies-Jones
PMCID: PMC496521  PMID: 5807872

Full text

PDF
324

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FAWCETT C. P., CIOTTI M. M., KAPLAN N. O. Inhibition of dehydrogenase reactions by a substance formed from reduced diphosphopyridine nucleotide. Biochim Biophys Acta. 1961 Nov 25;54:210–212. doi: 10.1016/0006-3002(61)90962-3. [DOI] [PubMed] [Google Scholar]
  2. FLEISHER G. A., WAKIM K. G., GOLDSTEIN N. P. Glutamic-oxalacetic transaminase and lactic dehydrogenase in serum and cerebrospinal fluid of patients with neurologic disorders. Proc Staff Meet Mayo Clin. 1957 Apr 17;32(8):188–197. [PubMed] [Google Scholar]
  3. GREEN J. B., OLDEWURTEL H. A., O'DOHERTY D. S., FORSTER F. M. Cerebrospinal fluid transaminase and lactic dehydrogenase activities in neurologic disease. AMA Arch Neurol Psychiatry. 1958 Aug;80(2):148–156. doi: 10.1001/archneurpsyc.1958.02340080018002. [DOI] [PubMed] [Google Scholar]
  4. GREEN J. B., OLDEWURTEL H. A., O'DOHERTY D. S., FORSTER F. M., SANCHEZ-LONGO L. P. Cerebrospinal fluid glutamic oxalacetic transaminase activity in neurologic disease. Neurology. 1957 May;7(5):313–322. doi: 10.1212/wnl.7.5.313. [DOI] [PubMed] [Google Scholar]
  5. JAKOBY R. K., JAKOBY W. B. Lactic dehydrogenase of cerebrospinal fluid in the differential diagnosis of cerebrovascular disease and brain tumor. J Neurosurg. 1958 Jan;15(1):45–51. doi: 10.3171/jns.1958.15.1.0045. [DOI] [PubMed] [Google Scholar]
  6. KARMEN A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest. 1955 Jan;34(1):131–133. [PubMed] [Google Scholar]
  7. KATZMAN R., FISHMAN R. A., GOLDENSOHN E. S. Glutamic-oxalacetic transaminase activity in spinal fluid. Neurology. 1957 Dec;7(12):853–855. doi: 10.1212/wnl.7.12.853. [DOI] [PubMed] [Google Scholar]
  8. LENDING M., SLOBODY L. B., MESTERN J. Effect of prolonged hypoxia on cerebrospinal fluid and plasma activity of GOT and LDH. Neurology. 1961 Jun;11:520–523. doi: 10.1212/wnl.11.6.520. [DOI] [PubMed] [Google Scholar]
  9. MANN S. H., DEPASQUALE N., PATERSON R. Cerebrospinal fluid-glutamic oxalacetic acid transaminase in patients receiving electroconvulsive therapy and in neurologic diseases. Neurology. 1960 Apr;10:381–390. doi: 10.1212/wnl.10.4.381. [DOI] [PubMed] [Google Scholar]
  10. MELLICK R. S., BASSETT R. L. THE CEREBROSPINAL-FLUID GLUTAMIC OXALOACETIC TRANSAMINASE ACTIVITY IN NEUROLOGICAL DISEASES. Lancet. 1964 Apr 25;1(7339):904–906. doi: 10.1016/s0140-6736(64)91629-0. [DOI] [PubMed] [Google Scholar]
  11. MYERSON R. M., HURWITZ J. K., SALL T. Serum and cerebrospinal-fluid transaminase concentrations in various neurologic disorders. N Engl J Med. 1957 Aug 8;257(6):273–276. doi: 10.1056/NEJM195708082570606. [DOI] [PubMed] [Google Scholar]
  12. SLOBODY L. B., YANG D. C., LENDING M., BORRELLI F. J., TYREE M. Effect of severe hypoxia on blood-cerebrospinal fluid barrier. Am J Physiol. 1957 Aug;190(2):365–370. doi: 10.1152/ajplegacy.1957.190.2.365. [DOI] [PubMed] [Google Scholar]
  13. WROBLEWSKI F., DECKER B., WROBLEWSKI R. Activity of lactic dehydrogenase in spinal fluid. Am J Clin Pathol. 1957 Sep;28(3):269–271. doi: 10.1093/ajcp/28.3.269. [DOI] [PubMed] [Google Scholar]
  14. WROBLEWSKI F., LADUE J. S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med. 1955 Oct;90(1):210–213. doi: 10.3181/00379727-90-21985. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES